Dow Down 0.58% Nasdaq Down 0.47%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
13.99 Down 0.13(0.92%) 9:39AM EDT - Nasdaq Real Time Price
Prev Close:14.12
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:23.50
Beta:0.75
Earnings Date:Oct 30 - Nov 3 (Est.)
Day's Range:13.94 - 14.04
52wk Range:11.80 - 19.75
Volume:15,886
Avg Vol (3m):154,858
Market Cap:479.98M
P/E (ttm):10.94
EPS (ttm):1.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OSIR

Comparison

Symbol% ChgMkt Cap
OSIRDown 0.92%479.98M
ABTDown 0.68%63.62B
BIIBDown 0.52%80.66B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.65
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.01
Quarterly EPS Est (Sep-14) :0.00
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing products to treat medical conditions in wound care, orthopedic, and sports medicine markets. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback